Stockscreener 앱 받기
8.00
0.12%
-0.010
전일 마감가:
$8.01
열려 있는:
$7.89
하루 거래량:
2.09M
Relative Volume:
0.79
시가총액:
$891.75M
수익:
$24.30M
순이익/손실:
$-145.57M
주가수익비율:
-6.015
EPS:
-1.33
순현금흐름:
$-149.17M
1주 성능:
+2.70%
1개월 성능:
+3.09%
6개월 성능:
+429.80%
1년 성능:
+55.04%
1일 변동 폭
$7.43
$8.17
1주일 범위
$7.43
$8.35
52주 변동 폭
$1.03
$9.70
Tango Therapeutics Inc Stock (TNGX) Company Profile
명칭
Tango Therapeutics Inc
전화
(857) 320-4900
주소
201 BROOKLINE AVENUE, BOSTON
TNGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
8.015 | 1.06B | 24.30M | -145.57M | -149.17M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.69 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.03 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.96 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
830.90 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-07-17 | 개시 | Jefferies | Buy |
| 2024-04-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-12 | 개시 | Piper Sandler | Overweight |
| 2023-12-08 | 개시 | B. Riley Securities | Buy |
| 2022-10-20 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | 개시 | SVB Leerink | Outperform |
모두보기
Tango Therapeutics Inc 주식(TNGX)의 최신 뉴스
Tango Therapeutics Flips To Profit And Banks Fresh Funding - Finimize
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - sharewise.com
Tango Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Tango Therapeutics reports Q3 EPS 14c, consensus (7c) - TipRanks
Tango Therapeutics, Inc. SEC 10-Q Report - TradingView
Tango Therapeutics reports Q3 net income, revenue jumps - MarketScreener
Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire
How Tango Therapeutics Inc. stock performs in rising dollar environment2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
Can Tango Therapeutics Inc. stock outperform in 2025 bull market2025 Earnings Surprises & Community Consensus Trade Alerts - newser.com
Why Tango Therapeutics Inc. is moving today2025 Market Sentiment & Safe Entry Point Alerts - newser.com
Ranking Tango Therapeutics Inc. among high performing stocks via toolsMarket Risk Summary & Safe Capital Growth Stock Tips - newser.com
Will Tango Therapeutics Inc. stock attract ESG investorsWeekly Earnings Recap & Capital Protection Trading Alerts - newser.com
Does Tango Therapeutics Inc. fit your quant trading modelAnalyst Upgrade & High Accuracy Swing Trade Signals - newser.com
Is Tango Therapeutics Inc. stock entering bullish territoryInsider Selling & Technical Entry and Exit Tips - newser.com
Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: W - GuruFocus
Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Long term hold vs stop loss in Tango Therapeutics Inc.Swing Trade & Accurate Intraday Trading Signals - newser.com
Why Tango Therapeutics Inc. stock is trending among retail tradersPortfolio Update Report & Weekly Breakout Opportunity Watchlist - newser.com
Short interest data insights for Tango Therapeutics Inc.Treasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
Tango Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - sharewise.com
Why Protagonist Therapeutics Stock Skyrocketed by Almost 30% Today - AOL.com
What is HC Wainwright's Estimate for TNGX FY2026 Earnings? - MarketBeat
How to build a dashboard for Tango Therapeutics Inc. stock2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Will Tango Therapeutics Inc. stock maintain dividend yield2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Multi asset correlation models including Tango Therapeutics Inc.Market Growth Review & High Conviction Investment Ideas - newser.com
Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? - Mitrade
Tango Therapeutics price target raised to $12 from $10 at Guggenheim - MSN
Tango Therapeutics’ Promising Update on TNG260 Clinical Study - MSN
TNGX FY2025 EPS Forecast Boosted by Cantor Fitzgerald - MarketBeat
Revolution Medicines and Tango Therapeutics Advance in Targeted Cancer Therapy Study - MSN
Tango Therapeutics (TNGX) Expected to Announce Earnings on Wednesday - MarketBeat
Tango Therapeutics Inc (TNGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
0.56%
자본화:
|
볼륨(24시간):